Zymeworks (ZYME) Retained Earnings (2021 - 2026)
Zymeworks recorded quarterly Retained Earnings of -$6.6 million in Q1 2026, down 7.99% quarter-over-quarter from -$6.1 million in Q4 2025, and down 2.48% year-over-year from -$6.7 million in Q1 2025.
Zymeworks' Retained Earnings history runs 6 years deep, the most recent figure standing at -$6.6 million for Q1 2026.
- In Q1 2026, Retained Earnings fell 2.48% year-over-year to -$6.6 million; the TTM figure through Mar 2026 stood at -$6.6 million (down 2.48% YoY), while the FY2025 annual figure was -$6.1 million, up 99.27% from the prior year.
- Retained Earnings came in at -$6.6 million for Q1 2026 at Zymeworks, down from -$6.1 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$6.0 million in Q3 2025 to a low of -$850.7 million in Q2 2025.
- A 5-year average of -$344.4 million and a median of -$7.9 million in 2024 frame the typical range for Retained Earnings.
- On a YoY basis, Retained Earnings climbed as much as 99.27% in 2025 and fell as far as 10662.32% in 2025.
- Zymeworks' Retained Earnings stood at -$6.7 million in 2022, then sank by 10073.25% to -$677.4 million in 2023, then decreased by 22.57% to -$830.3 million in 2024, then surged by 99.27% to -$6.1 million in 2025, then slipped by 7.99% to -$6.6 million in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$6.6 million, -$6.1 million, and -$6.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 130.89 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 36.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Zymeworks | 1.84 Bn | 1.47 Bn | - | -6.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.57 Mn |
| Dec 31, 2025 | -6.08 Mn |
| Sep 30, 2025 | -6.05 Mn |
| Jun 30, 2025 | -850.65 Mn |
| Mar 31, 2025 | -6.41 Mn |
| Dec 31, 2024 | -830.34 Mn |
| Sep 30, 2024 | -797.83 Mn |
| Jun 30, 2024 | -7.90 Mn |
| Mar 31, 2024 | -709.09 Mn |
| Dec 31, 2023 | -677.44 Mn |
| Sep 30, 2023 | -662.96 Mn |
| Jun 30, 2023 | -7.81 Mn |
| Mar 31, 2023 | -583.12 Mn |
| Dec 31, 2022 | -6.66 Mn |
| Sep 30, 2022 | -6.66 Mn |
| Dec 31, 2021 | -683.10 Mn |